Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Bone Marrow Transplantation

• Publication date

  1995-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 8750272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin. Bone Marrow Transplantation Team.

  1994cited by this paper
• Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent.

  1993cited by this paper
• Pure red cell aplasia following ABO‐incompatible bone marrow transplantation: response to erythropoietin

  1993cited by this paper
• Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.

  1993cited by this paper
• Comparison of chromosome studies on PHA-stimulated blood and unstimulated bone marrow cells in recipients of lymphocyte depleted grafts using counterflow centrifugation.

  1993cited by this paper
• Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.

  1992cited by this paper
• Changing trends in marrow transplantation for aplastic anemia.

  1992cited by this paper
• Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant.

  1992cited by this paper
• Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin.

  1991cited by this paper
• Immunohematologic complications of bone marrow transplantation.

  1991cited by this paper
• Treatment of pure red-cell aplasia following major ABO-mismatched T-cell-depleted bone marrow transplantation

  1991cited by this paper
• Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation.

  1991cited by this paper
• Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin [letter; comment]

  1991cited by this paper
• Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation.

  1990cited by this paper
• Pure red-cell aplasia of long duration after major ABO-incompatible bone marrow transplantation.

  1990cited by this paper
• Reconstitution of antibody response after allogeneic bone marrow transplantation: effect of lymphocyte depletion by counterflow centrifugal elutriation on the expression of hemagglutinins.

  1990cited by this paper
• Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation.

  1990cited by this paper
• Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO‐mismatched allogeneic bone marrow transplant recipient

  1989cited by this paper
• Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse.

  1989cited by this paper
• A double buffy coat method for red cell removal from ABO‐incompatible marrow

  1989cited by this paper
• Host and donor erythrocyte repopulation patterns after allogeneic bone marrow transplantation analysed with antibody‐coated fluorescent microspheres

  1989cited by this paper
• A Fluorescent Microsphere Method for the Investigation of Erythrocyte Chimaerism after Allogeneic Bone Marrow Transplantation Using Antigenic Differences

  1988cited by this paper
• IMMUNOHEMATOLOGIC CONSEQUENCES OF MAJOR ABOMISMATCHED BONE MARROW TRANSPLANTATION

  1988cited by this paper
• Comparison of techniques for dealing with major ABO-incompatible marrow transplants.

  1987cited by this paper
• ABO-incompatible bone marrow transplantation: in vivo adsorption, an old forgotten method.

  1987cited by this paper
• Immunohematologic problems arising from ABO incompatible bone marrow transplantation.

  1987cited by this paper
• Obstacle to red cell engraftment due to major ABO incompatibility in allogeneic bone marrow transplants (BMT): quantitative and kinetic aspects in 58 BMTs.

  1987cited by this paper
• ERYTHROCYTE REPOPULATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION ANALYSIS USING ERYTHROCYTE ANTIGENS

  1987cited by this paper
• Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor.

  1987cited by this paper
• Transplantation of Major ABO‐Incompatible Bone Marrow Depleted of Red Cells by Hydroxyethyl Starch 1

  1985cited by this paper
• BONE MARROW REPOPULATION CAPACITY AFTER TRANSPLANTATION OF LYMPHOCYTE‐DEPLETED ALLOGENEIC BONE MARROW USING COUNTERFLOW CENTRIFUGATION

  1984cited by this paper
• A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation

  1984cited by this paper
• Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion.

  1982cited by this paper
• ABO‐INCOMPATIBLE MARROW TRANSPLANTS

  1982cited by this paper
• ABO-incompatible marrow transplants.

  1978cited by this paper

• Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation

  2022cites this paper
• Transfusion Therapy in Specific Clinical Situations

  2021cites this paper
• Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study

  2021cites this paper
• Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant

  2020cites this paper
• Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.

  2018cites this paper
• Assessing the impact of ABO incompatibility on major allogeneic hematopoietic stem cell transplant outcomes: a prospective, single-center, cohort study

  2018cites this paper
• ABO blood group mismatched hematopoietic stem cell transplantation

  2016cites this paper
• ABO blood group mismatched hematopoietic stem cell transplantation.

  2016cites this paper
• ABO blood group antigen mismatch has an impact on outcome after allogeneic peripheral blood stem cell transplantation

  2016cites this paper
• Transfusion support issues in hematopoietic stem cell transplantation.

  2015cites this paper
• Transfusion indications for patients with cancer.

  2015cites this paper
• Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

  2013cites this paper
• Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients following Hematopoietic Stem Cell Transplantation

  2012cites this paper
• Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation

  2012cites this paper
• Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins

  2009cites this paper
• Incompatibilité ABO et greffe allogénique de cellules souches hématopoïétiques à l’ère des conditionnements non myéloablatifs

  2007cites this paper
• The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from kostmann syndrome

  2007cites this paper
• Chapter 39 – Transfusion to Bone Marrow or Solid Organ Transplant Recipients

  2007cites this paper
• Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO‐incompatible allogeneic haematopoietic stem cell transplantation

  2007cites this paper
• Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation

  2007cites this paper
• The Effect of Donor Leukocyte Infusion on Refractory Pure Red Blood Cell Aplasia after Allogeneic Stem Cell Transplantation in a Patient with Myelodysplastic Syndrome Developing from Kostmann Syndrome

  2007cites this paper
• [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].

  2007cites this paper
• After major ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B

  2005cites this paper
• Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants

  2005cites this paper
• Isotype‐specific detection of ABO blood group antibodies using a novel flow cytometric method

  2005cites this paper
• Immune hemolysis associated with transplantation.

  2005cites this paper
• The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation

  2005cites this paper
• Immune hemolysis associated with transplantation 147 ntibodies Other Than Those of the ABO Blood roup System

  2005cites this paper
• Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion

  2004cites this paper
• Chapter 12 – Immune Hemolysis Associated with Transplantation

  2004cites this paper
• Changes of isoagglutinin titres after ABO‐incompatible allogeneic stem cell transplantation

  2003cites this paper
• ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation

  2003cites this paper
• ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning

  2002cites this paper
• Engraftment of early erythroid progenitors is not delayed after non‐myeloablative major ABO‐incompatible haematopoietic stem cell transplantation

  2002cites this paper
• Relevance of Blood Group Differences and Antibodies in Allogeneic Stem Cell Transplantation

  2002cites this paper
• The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplant.

  2002cites this paper
• Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review

  2001cites this paper
• Major ABO不適合骨髄移植後に発症した赤芽球〓の1例

  2001cites this paper
• Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

  2001cites this paper
• Hematopoietic stem cell transplantation between red cell incompatible donor–recipient pairs

  2001cites this paper
• Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.

  2000cites this paper
• Passenger lymphocyte syndrome with severe hemolytic anemia due to an anti‐Jka after allogeneic PBPC transplantation

  2000cites this paper
• Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components

  2000cites this paper
• Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation

  2000cites this paper
• An overview of the use of flow cytometry in the analysis of mixed red cell populations.

  1999cites this paper
• Time‐course expression of polypeptides carrying blood group antigens during human erythroid differentiation

  1999cites this paper
• Hemolysis associated with transplantation

  1998cites this paper
• [Erythropoietin: biochemical characteristics, biologic effects, indications and results of use in hematology].

  1997cites this paper
• Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin

  1997cites this paper